30+ years in medicine and 15+ years in drug development, with a track record including FDA approvals and successful acquisitions.
Sid Labed is a serial biotech founder and Harvard Medical School alum
former Biogen Senior Translational/Clinical Pharmacologist Leader, overseeing preclinical development at EvoDenovo.
Dr. Brock Grill is a Professor at the Department of Pediatrics, University of Washington; his lab laid the foundation for the GPR139 opioid use disorder program.
Drug Development advisor
